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of the initial platelets remained in circulation. Phosphate adsorp-
tion studies by stirred bath and perfusion experiments indicated
that 250-g column regularly reduced serum phosphate more than
50% from the initial level of 16 mgIIOO ml within 3 hours. Blood
chemistry determinations during perfusion experiments demon-
strated the specificity of the system for phosphate. Fine particle
generation was negligible. Elution of aluminium ions from the
alumina columns was not detected. These results indicate that
coated alumina columns may be used for the treatment of hyper-
phosphatemia in hemodialyzed patients.
Change in incidence of childhood urolithiasis (UL) in Israel over
a 10-year period. H. Stark. Beilinson Hospital and Tel-Aviv Uni-
versity, Petah Tiqva, Israel. A review of clinical and epidemio-
logic aspects of childhood UL in Israel in 1960—64 showed totally
different pictures among three ethnic subpopulations: among
Ashkenazi Jewish children (of EuropeanlAmerican extraction),
UL was rare and sporadic, whereas among Arab and non-Ashke-
nazi Jews (of AsianlAfrican extraction) it was common and typi-
cal of the epidemic form of UL. A review of the incidence 10
years later (1970—74) demonstrated a dramatic fall in the in-
cidence of UL among Arab and non-Ashkenazi Jewish children
as compared to Ashkenazi Jews: from 18.5:1 to 1.5:1 and from
17.5:1,0 to 2.5:1.0, respectively. As climatic and geographic fac-
tors are common to all ethnic groups, it is felt this drop in in-
cidence is the result of improved dietary intake among the Orien-
tal communities of Israel.
Idiopathic hypercalciuria in childhood: Metabolic studies. M.
Tieder, H. Stark, and R. Shainkin-Kerstenbaum. Beilinson I-los-
pital, Petal, Tiqva and Soroka Hospital, Beer-S heba, Israel. Of
20 children with urolithiasis investigated over a 10-year period, 9
demonstrated idiopathic hypercalciuria (IH). Two more children
were seen with IH but without urolithiasis. Of these 11 cases of
IH, 9 were male and 2 female. Lithiasis was first diagnosed at
5l/4101/2 years. None of the patients demonstrated disorders of
endocrine or renal tabular function (including concentrating ca-
pacity) of growth disturbance. Metabolic studies were performed
on 8 patients (6 male, 2 female) at ages 8 to 21 years (mean, 141/2
years) and on 10 controls (C) (7 males, 3 females) aged 6 to 14
years (mean, 10'/4 years). Serum calcium and 25HCC levels were
identical in IH and C. Serum parathormone (PTH) levels showed
no difference, whereas urinary cAMP was significantly lower in
IH (both fasting and after calcium loading). Serum thyrocalcito-
nm (TCT) was significantly higher in IH than in C. Both serum P
and TmP/GFR were significantly lower in IH.
UCa/creat
Fast-
ing
Ca
load PTH UcAMP TCT P.
TmP/
GFR
IH 0.11 0.34 0.83 2.4 0.24 4.0 3.9
±0.07 ±0.15 ±0.40 ±1.1 ±0.12 ±0.6 ±0.7
C 0.06 0.12 0.90 5.2 0.14 4.9 5.2
±0.04 ±0.12 ±0.30 ±1.9 ±0.07 ±0.4 ±0.9
p NS <0.01 NS <0.01 <0.001 <0.001 <0.01
Our findings suggest a mechanism for IH in childhood similar
to that proposed for IH in adults by Shen et al, namely, a renal
tubular reabsorptive capacity for phosphate at the lower limit of
normal produces a relatively low serum phosphate level. This
stimulates production of I,25(OH)2 vitamin D, leading to in-
creased intestinal calcium absorption, which decreases PTH and
increases TCT release. The combination of these events causes
hypercalciuria.
Elevated taste threshold for salt in hypertensive subjects. R. J.
Viskoper and U. Lugassy. Department of Nephrology, Barzilai
Medical Center, Ashkelon, Israel. Taste threshold for salt was
measured in 17 hypertensive and 23 normotensive subjects. The
mean age of the hypertensive subjects was 43.8 ± 3.6 and of the
normotensives, 37.8 ± 2.6 years. None of the hypertensive sub-
jects were treated with diuretics prior to the test. Taste threshold
was tested by means of a series of dilutions from 1/1000 to 20/
1000 of a concentrated salt solution (175 g in 500 cc distilled wa-
ter). The lowest salt concentration causing a definite salt sensa-
tion when applied to the tongue was recorded. In hypertensive
subjects, the lowest salt dilution tasted was 9.23 ± 0.77%; in
the normotensive subjects mean salt dilution tasted was
6.34 ± 0.27%, P < 0.005. Conclusion. Hypertensive subjects
have a definitely higher taste threshold for salt than do normoten-
sive subjects.
Increased blood pressure response to static exercise in hyperten-
sive offspring. R. J. Viskoper and M. Glisser. Department of
Nephrology, Barzilai Medical Centre, Ashkelon, israel. Thirty-
seven normotensive males of hypertensive parents (one parent)
(group A) were compared with age-matched 66 normotensive
males of normotensive parents (group B) (ages 12 to 24 years;
average age, 16 years). Heart rate and blood pressure were mea-
sured after 10 mm of supine position and at the end of I mm of
static exercise. Static exercise was performed by the help of an
aneroid manometer for 1 mm at a level of 30% of maximal per-
formance. The blood pressure values are expressed as percen-
tiles. Corrected for age, the upper limit of normal range of per-
centile analysis is 94%. Results are:
Group A Group B
At rest
Heart rate,beats/min 68.8 ± 1.5 65.0 ± 0.9NS
% of subjects above 0 0
94 percentile
After static effort
Heart rate, beats/mm 20.1 ± 1.6 18.1 ± l.2NS
Diastolic BP, % subjects 37.8 19.6 (P < 0.05)
above 94 percentile
Both systolic and diastolic 24.3 4.5 (P < 0.01)
BP above 94 percentile
Conclusions. (1) Normotensive offspring of hypertensive parents
have an increased blood pressure response to static effort, when
compared to aged-matched offspring of normotensivc parents.
(2) This test might allow for early detection of 'hypertensive fea-
tures" of hypertension-prone normotensives.
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Urinary enzyme excretion induced by nephrotoxic agents in rats.
Francois Ansermet and Jacques Diezi. Institut de pharmacolo-
gic de l'Université, Lausanne, Switzerland. As increased urinary
excretion of renal enzymes has been reported to be an indicator
of minimal renal damage, we have compared, in rats treated with
low doses of known nephrotoxic agents, changes in enzyme ex-
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cretion and in overall kidney function as indicators of renal dam-
age. Male Wistar rats were poisoned by a single injection i.p. of
either HgC12 (0.5, 0.75, or 1.0 mg kg'), gentamicin (4.0 or 40
mg . kg'), or tobramycin (3.21 or 32.1 mg . kg1, equimolar with
gentamicin). Unanesthetized rats were infused i.v., at various
times within 48 hours following injection of the toxin, with iso-
tonic saline (0.1 ml . min1). Alkaline phosphatase EC 3.1.3.1
(AP), lactate deshydrogenase EC 1.1.27 (LDH), leucine amino-
peptidase EC 3.4.11 (LAP), and lysozyme excretion was mea-
sured in urine samples collected during 4-hour periods. Overall
kidney function was evaluated by measuring GFR (inulin clear-
ance), maximal secretory capacity for para-aminohippurate
(TMPAH), electrolyte excretion, proteinuria, and serum urea con-
centration. HgC12. 10 to 14 hours after the lowest dose of Hg,
AP, LAP, and LDH excretion was increased and TmPAH was de-
pressed, while other renal function tests remained normal.
After 20 to 24 hours, HgC12, and depending of the dose of Hg,
LAP, and LDH excretion, was 2.3 to 19.6 times larger in treated
than it was in control rats. AP was slightly but significantly in-
creased, and TmPAH was depressed. The other functional tests
and lysozyme excretion remained unaltered. Enzyme excretion
returned to normal 44 to 48 hours after injection of Hg, but
TmPAH remained significantly lower than normal. Gentamicin.
20 to 24 hours after injection of the lower dose, AP, LAP and
LDH increased significantly. After the larger dose, LDH excre-
tion, only, increased significantly. All other functional tests re-
mained unchanged, except TmPAH which decreased after the
larger dose. Changes induced by tobramycin at equimolar doses
were similar to those elicited by gentamicin. Thus, increased
excretion of AP, LAP, and LDH appears to be an early and
reliable sign of renal damage induced by low doses of HgCI2,
gentamicin, or tobramycin.
Renal phosphate transport: Parallel changes in whole kidney,
proximal tubule, and brush border membrane vesicles. J. P. Bon-jour, R. Mühlbauer, H. Fleisch, R. Sb!!, H. Murer, and R.
Kinne. Pat hophysiologisches Institu I der Universität Bern,
Bern, Switzerland, and Max-Planck-Jnstitut fur Biophysik,
Frankfirt/Main, West-Germany. Renal transport of inorganic
phosphate (P1) in rats has been studied (I) in whole kidney by
clearance technique, (2) in superficial proximal and distal tubules
by free-flow Inicropuncture, and (3) in brush border membrane
vesicles isolated from cortical tissue. The influence of the follow-
ing factors has been investigated: (a) variation in dietary P1 (0.2
vs. 1.2% phosphorus diet), (b) chronic thyroparathyroidectomy
(TPTX), (c) chronic administration of 1 ,25-dihydroxyvitamin D3
(1,25 (OH)2D3, 2 x 13 pmoles/day i.p. for 7 days), and (d) admin-
istration of disodium ethane-l-hydroxy-1, 1-diphosphonate
(EHDP) at a dose (10mg P/kg s.c. for 7 days) which inhibits bone
mineral deposition. The changes in the overall tubular transport
of P, promoted by these factors were associated with parallel al-
terations in proximal reabsorption and in the sodium-dependent
P1 uptake by isolated brush border membrane vesicles. The ef-
fect of dietary P1, chronic TPTX, 1,25 (OH)2D3, or EHDP ap-
pears to be specific for the sodium-dependent P, transport system
bound to the brush border membrane. The changes of the P1
transport rate were not accompanied by alterations in the activi-
ty of alkaline phosphatase measured either in the whole kidney
cortex homogenates or in the brush border membrane prepara-
tions. These results would favor the view that the main rate-lim-
iting and regulated step in the net P, reabsorption is the trans-
location of the ion across the luminal membrane of the proximal
tubule. However, they do not exclude the possibility of other
sites of regulation, since free-flow micropuncture data suggest
that dietary P1, chronic thyroparathyroidectomy, 1 ,25-dihy-
droxyvitamin D3, and EHDP also affect the P1 transport beyond
the proximal tubule, particularly along the terminal nephron.
Membranous glomerulonephritis in renal cadaver allotrans-
plants. J. Briner, U. Binswanger, and F. Largiadèr. Institut für
Pathologie, Nephrologische Station, Chirurgische Klinik A,
Universitiitsspital Zurich, Switzerland. Severe glomerular
changes develop in a substantial number of renal cadaver allo-
grafts. Apart from transplant glomerulopathy, several different
morphologic types of glomerulonephritis (e.g., dense deposits
disease, IgA nephritis) have been documented. They are due to
various pathogenetic mechanisms (e.g., recurrent glomerulone-
phritis, de novo glomerulonephritis). A membranous type of gb-
merulonephritis has only rarely been reported after trans-
plantation. Among over 400 kidney allotransplantations we ob-
served three cases of de novo membranous glomerulonephritis in
patients transplanted because of renal failure due to chronic py-
ebonephritis, chronic glomerulonephritis, and medullary sponge
kidney. One case of recurrent membranous glomerubonephritis
was observed as well. Renal transplant biopsy showed only mi-
nor glomerular changes on light microscopy but typical mem-
branous glomerubonephritis on electron microscopy and immu-
nofluorescence. All patients developed nephrotic syndrome with
severe proteinuria (11.5 to 15.0 g/day) 5 to 12 months after trans-
plantation. The excretory function was slightly impaired and
showed slow deterioration during observation periods up to 18
months.
Should dietary sodium be restricted during treatment of essen-
tial hypertension with thiazide diuretics? P. van Brummelen and
M. A. D. 1W. Schalekamp. Department of Nephrology, Universi-
ty Hospital Leiden, and Department of Internal Medicine,
Erasmus University, Rotterdam, The Netherlands. To determine
the influence of dietary sodium intake on the effects of hydro-
chlorothiazide (HCT) on blood pressure (BP), serum elec-
trolytes, renin, and aldosterone, we studied nine male patients
with uncomplicated essential hypertension during the following
therapeutic regimes: (1) sodium restriction alone (50 mmoles/
day), (2) sodium restriction combined with HCT (50 mg twice
daily), (3) HCT alone, and (4) sodium restriction combined with
HCT. Low-sodium diet alone and HCT alone lowered BP to the
same extent. The combination of HCT and sodium restriction
had no extra effect on supine BP, but elicited complaints of dizzi-
ness and weakness in each patient, and overt orthostatic hypo-
tension in three cases. Sodium restriction during HCT treatment
caused hyponatremia and aggravated hypokalemia. Hypona-
tremia could not be accounted for solely by changes in cumula-
tive sodium balance. Plasma renin concentration rose markedly
during the combined treatment. Plasma aldosterone was normal
during HCT alone, but elevated when HCT was combined with
sodium restriction. These results cast some doubt on the thera-
peutic value of prescribing a low sodium diet to patients with
essential hypertension treated with thiazide diuretics. Over-
activity of the renin-angiotensin-aldosterone system during this
regime might explain both the lack of a beneficial effect on BP
and the adverse influence on serum potassium.
Acute plasma parathormone fluctuations induced by varying
calcium dialysate during chronic hemodialysis. P. Burckhardt
andf. P. Wauters. Department of Medicine, Centre Hospitalier
Universitaire, Lausanne, Switzerland. The high dialysate cal-
cium concentration (D-Ca) of 8 mg% recommended to lower
plasma parathormone (PTH) levels during hemodialysis (HD)
causes clinical hypercalcemia and at long term does not prevent
the progression of hyperparathyroidism. A reduction of the
plasma Ca oscillations during and between HD sessions was
achieved to avoid clinical symptoms and eventually control bet-
ter FF11 secretion. Nine patients, age 33 to 63 years, on chronic
HD for 26 months (range, 1 to 59), were dialysed three times 3
to 5 hours/week against a D-Ca of 8 mg%. Measurements of
plasma Ca, PTH, and proteins were performed before, during, at
the end of 2, 4, 8, 12, 24, and 48 hours after completion of the
dialysis session (phase 1). Subsequently, D-Ca was changed
from 8 to 7 mg% and the measurements were repeated 3 months
later (phase 2). During HD, mean plasma Ca rose from 9.40 ±
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0.21 (5EM)to 11.65 0.45 mg% in phase land from 9.05 0.21
to 10.43 0.16 mg% in phase 2. Mean plasma PTH (measured
with AS211/32) decreased from 0.44 0.07 to 0.35 ng/ml
in phase and from 0.63 0.1 to 0.42 0.06 ng/ml in phase 2.
After HD, mean plasma Ca decreased gradually and reached the
initial values 48 hours later. Mean plasma PTH increased after
HD and came close to the initial value 8 hours later. In the 2
patients with the highest basal PTH values, a transient increase
above the basal levels was observed. The correlations between
PTH and Ca became significant in all nine patients only when Ca
was corrected for proteins. The regression lines of the correla-
tions between PTH and corrected plasma Ca were flat in patients
with normal basal PTH levels (<0.35 nglml) and steep in patients
with high basal PTH levels (>0.70 nglml). The slope of the re-
gression lines and the basal PTH levels were positively corre-
lated (r = 0.685, P < 0.05). Conclusion. By lowering the D-Ca
from 8 to 7 mg% in a group of HD patients with mainly normal or
slightly elevated basal PTH values: (I) postdialysis symptoms of
hypercalcemia could be avoided, (2) fluctuations of plasma Ca
were reduced during and between HD sessions, (3) plasma PTH
fluctuated in the same negative correlation with plasma Ca as
before but basal PTH levels showed an upward trend. This is
probably related to lower basal plasma Ca levels. Ca supplemen-
tation between HD sessions seems therefore indicated.
Unusual incidence of membranous glomerulonephritis after gold
therapy for rheumatoid arthritis: A side effect of a new drug? H.
R. Burger, J. Briner, B. Güriler, U. Binswanger. Pathologisches
Institut und Nephrologische Station, Unii'ersitatsspital, Zurich,
Switzerland. Nephropathies after gold therapy for rheumatoid
arthritis are well known. Clinical symptoms include proteinuria
or nephrotic syndrome. Morphologically, a membranous glomer-
ulonephritis has been documented frequently. Since the begin-
ning of 1978, we found an unusually high incidence of proteinuria
in patients with rheumatoid arthritis. In five patients, 17 to 65
years old, who had been treated with gold salts and had devel-
oped severe proteinuria, percutanous needle biopsies showed a
membranous glomerulonephritis with minimal changes as ob-
served by light microscopy, but IgA deposits when studied by
immunofluorescence and multiple dense epimembranous depos-
its by electron microscopy. Furthermore so called aurosomes"
mostly located in the cytoplasm of the glomerular epithelial cells
could be demonstrated. The unusual incidence of almost identi-
cal cases coincides with the introduction of sodium aurothiomal-
ate as a new gold preparation containing the double amount of
gold as compared to previously used drugs. The increased total
amount of gold given or the chemical nature of the new com-
pound might, therefore, be related to the higher incidence of gold
nephropathy.
Continuous ambulatory peritoneal dialysis (CAPD). A. Colombi,
C. L. Rosenthal, and B. Truniger. Nierenstation, Med. Klinik,
Kantonsspital, Luzern, Switzerland. Seven patients (four male,
three female), 34 to 65 years old, have been treated by CAPD.
Six patients had 4 fillings of dialysate per day (2 liters each), one
patient had five fillings. Dialysate was changed at 7 AM., 12
AM., 5 P.M., and 11 P.M. A modified Tenckhoff catheter was
implanted into the peritoneal cavity with the fascia closed tightly
between two Dacron cuffs. The skin exit of the catheter was cov-
ered by a Steripad which served at the same time to fix the tub-
ing. Blood chemistry in these patients was: urea 104 27 mg/dl
(mean sE,i), creatinine 8.7 1.7 mgldl, phosphorus 3.8 2.2
mg/dl, uric acid 5.1 1.0 mg/dl, sodium 137.0 4.0 mEq/liter,
potassium 4.1 0.7 mEq/liter, and total calcium 9.3 0.7 mg/dl
(N 30). After 8 to 10 hours, the concentration of solutes in the
dialysate was close to that in blood, with a correlation coefficient
of 0.98 for urea, 0.93 for creatinine, 0.90 for potassium, 0.84 for
uric acid, 0.82 for phosphorus, 0.80 for sodium. Total calcium
concentrations differed because of protein binding in blood. The
measurements in the 'night dialysate outflow" appear appropri-
ate for routine laboratory check-up. Within 4 weeks of treat-
ment, hematocrit increased from 24 5.7 to 28 5.9, as com-
pared to 25.0 and 25.2, respectively, in 30 home-hemodialyzed
patients. Six out of seven patients had normal blood pressure
after 2 weeks of CAPD. Mean protein loss was 7.4 g/24 hour, but
was compensated for by normal food intake. After 4 weeks of
treatment, protein in serum averaged 6.4 g/dl. in 1780 tubing con-
nections, two episodes of peritonitis occurred, both due to
Staph. haem. They could be controlled ambulatorily by cephalo-
thin (150 to 250 mg twice a day), added to the dialysate. No cath-
eter obstruction occurred. In our experience, CAPD appeared to
be an excellent method for treating patients with end-stage renal
failure. Good control of uremia and hypertension, without im-
pairment of patient activity, is achieved at a very low cost.
inhibition of sodium-retaining effect of aldosterone by thyroid
hromone in the mammalian kidney. J. Diezi, M. Nenniger, and
B. C. Rossier. Institut de Pharmacologic de l'Université, Lao-
san/Ic, Switzerland. It has been shown that thyroid hormones
inhibit the natriferic effect of aldosterone (A) in the toad bladder.
The present experiments were designed to investigate the pos-
sible occurrence of such antagonism in the mammalian kidney.
Sixty-two male Wistar rats were adrenalectomized and given
NaCl 0.9% as drinking fluid. Three days later, six urine collec-
tions (1 hour each) were obtained before (2 coIl.) and after (4
coIl.) iv. A (2 injections of 1 g/l00 g body wt, 2 hours apart). In
31 rats (group 1), 50 zg/l00 g bw triiodothyronine ('I'3) were given
i.p. 20 mm before the first injection of A; 22 rats (group 2) re-
ceived the vehicle alone; 9 rats (group 3) were injected with re-
verse-T3 instead of the active hormone, at the same dose. All
animals were infused iv. with isotonic saline at a slow rate (0.03
mlJmin). Urine flow, Na and K concentration in urine were mea-
sured. In groups 2 and 3, absolute Na excretion decreased by
approx. fivefold (P < 0.001) from pre-A to the last post-A collec-
tion; K excretion increased by approx. threefold. In contrast, Na
excretion did not decrease significantly in group I after A; K
excretion increased as in controls. Absolute Na excretion was
significantly higher (P < 0.05) during the last urine coil, in group
I, than it was in groups 2 and 3. When Na excretion following A
was normalized, for each rat, with respect to pre-A excretion
rate, natriuresis was significantly higher (P < 0.05) in group 1
than it was in groups 2 and 3 from the second hour after A and
later. These results suggest that in euthyroid rats, a single high
dose ofT3 may inhibit the antinatriuretic, but not the kaliuretic
effects of A. The mechanism and the physiologic role of this in-
teraction remain to be determined.
Radloimmunoassay for urinary prostaglandins PGE2 and
PGEFa. J. Dhrr, P. Glasson, H. Maron, M. B. Vallotton, and F.
Dray. Division d'Endocrinologie, Département de Médecine,
Hdpital Cantonal, Genève, Switzerland. Using specific antisera
kindly provided by the Pasteur Institute, a RIA has been devel-
oped for urinary PGE2 and PGEF2a. Three milliliters of urine,
acidified to pH 2.5 to 3.0 with citric acid, is twice extracted with
6 ml of ethyl acetate:cyclohexane, 1:1. The extract is chromato-
graphed on silicic acid columns by a step-wise elution with in-
creasing concentrations of methanol in benzene:ethyl acetate,
3:2, to separate PGE and PGF fractions. The recoveries, as mea-
sured by tracer are 83.8 5.8% (mean so, N = 83) for PGE2
and 83.4 3.7% (N = 89) for PGF2 when both tracers are used
together in the same sample and 80.0 2.2% (N 4) and 80.2
1.7% (N = 4) (NS), respectively, for PGE2 and PGF2a when the
tracers were used separately, indicating a very low cross con-
tamination. The standard curves have the following character-
istics:
Final
Cpm
tracer
dilution
of the
antiserum Bo NSB
50%
displacement,
pg
E2
——2000 1:24,000 41.3 2.4 1.9 0.3 5.6 0.4
F2o —2000 1:76,500 37.4 1.5 1.9 0.2 15.8 0.7
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Intraassay variability is 3.8% and 6.3% (N = 8) for PGE2 and
PGF2cs respectively. Interassay variability is 10.7% (N = 11) and
8.0% (N = 12) respectively for PGE2 and PGF2a. In normal sub-jects on uncontrolled salt intake without medication, PGE2 and
PGF2o are similar in both sexes with 300.5 50.3 and 1180.3
147.1 ng124 hours for PGE2 and F2a (mean scM; N = 17).
Conclusion: A new tool is offered to study the variation of uri-
nary PG's under various conditions in rats and men and is cur-
rently being applied to evaluate their relation with ADH and the
renin-angiotensin-aldosterone system.
Kinetics of amikacin in renal parenchyma. J. Fabre, F. Ma-
laisse-Lagae, M. Rudhardt, and M. Amherdt. Policlinique de
inédecine, Division de néphrologie, Département de médecine
et Département de morphologie, Geneva, Switzerland. Amino-
glycoside antibiotics accumulate in the renal cortex and remain
there for several months. The present study of tissue kinetics
describes the renal behavior of amikacin which in this respect
has not yet been investigated. (I) Wistar rats received 25 mg/kg of
amikacin i.p. Concentrations of amikacin were as follows
(bioassay, means of 6 rats so):
patients. PRA and plasma angiotensin I concentration (Al) rose
only in the nine responders, while both responders and non-
responders decreased their plasma angiotensin II and aldoste-
rone concentrations. Blood pressure response was not signifi-
cantly correlated with pretreatment PRA (r =
—0.29). However,
during treatment a significant correlation (r =
—0.58; P < 0.05)
was observed between Al and mBP changes. Two patients pre-
sented with a rash and a febrile reaction. These data suggest that
SQ 14225 is an effective antihypertensive agent in renovascular
hypertension and in some cases of essential hypertension regard-
less of their renin status, but not in primary aldosteronism. Its
mechanism of action does not appear to depend entirely on the
inhibition of the last step of the renin-angiotensin system.
Pathophysiologic renal changes during hypoxemia in the rabbit.
J. P. Guignard and B. Filloux. Service de Pediatric, CHUV,
Lausanne, Switzerland. Respiratory distress with severe hypox-
emia is a common cause of oliguria and renal insufficiency in
neonates. In animal models, acute hypoxemia has produced con-
flicting results. Experiments were performed in mechanically-
Time after injection
1 hr 6 hrs 24 hrs 72 hrs 8 days 15 days
Cortex, pIg 139 21 156 21 130 39 100 16 50 10 19 10
Medulla, pglg 112 2! 21 3 17 10 13 5 not measurable
Serum, pg/mI 28 10 traces 0 0 0 0
Amikacin accumulated in the cortex with maximal concentra-
tions that were six times the serum peak (as opposed to 20 times
for gentamicin or sisomicin). It disappeared very slowly (t /2 =
122 hours). tn the medulla the accumulation was less marked;
there was none in 8 other organs studied. Small amounts of
amikacin could still be found in the urine 2 weeks after the injec-
tion. (2) Six hours after the injection of 3H-amikacin, high-resolu-
tion autoradiographs of kidneys showed an exclusively intra-
cellular accumulation of radioactivity, mostly in the lysosomes
of the proximal tubular cells. (3) Ligation of both ureters 20
hours earlier markedly increased the renal accumulation of
amikacin (content of amikacin 6 hours after injection of 25 mgI
kg: cortex 729 117 pg/g, medulla 279 56, serum 52 11).
The continued penetration into tubular cells even with a strong
reduction of glomerular filtration, i.e. of reabsorption, suggests a
possible entry through the basal pole. Summary. Amikacin accu-
mulates and persists in the renal cortex and more specifically in
the lysosomes of proximal tubular cells, a fact that correlated
well with its nephrotoxicity. Amikacin probably is subject to
bidirectional tubular transport (reabsorption as well as secre-
tion). Acute urinary obstruction increases the accumulation and
consequently the risk of toxicity.
An oral angiotensin-converting enzyme inhibitor for the treat-
ment of hypertension. L. Favre, M. Frazer, D. N. McKinstry,
and J. W. Hollifield. Vanderbilt University Medical School,
Nashville, Tennessee, USA. The effects of chronic converting-
enzyme inhibition with SQ 14225 were studied in 18 hypertensive
patients treated up to 6 months with daily dosage ranging from
200 to 1000 mg. Nine patients including four with renovascular
hypertension, three with normal renin, and two with low renin
essential hypertension had a highly significant decrement (—27.2
3.1 mm Hg; mean sEM) in mean blood pressure (mBP) which
was normalized (102.5 2.1 mm Hg) on a regular salt diet. Nine
patients including one with high renin, two with normal renin,
and four with low-renin essential hypertension, as well as two
patients with an aldosterone-producing adenoma, did not re-
spond to SQ 14225 alone. After addition of a diuretic, they had a
significant mBP decrease (—18.6 6.3mm Hg) although hyper-
tension was adequately controlled in only five of them. Direct
assay of converting-enzyme showed a significant inhibition in all
ventilated anesthetized rabbits to further define the patho-
physiologic changes occurring after acute hypoxemia. Acute
normocapneic hypoxemia (Pa02, 45 mm Hg) induced a marked
decrease in urine flow, effective renal plasma flow, and elec-
trolyte excretion, without significantly changing systemic blood
pressure or GFR. These changes were reversible, and control
values were attained within 1 hour of restoring normal Pa02. In
response to the slight metabolic acidosis induced by hypoxemia,
urine pH and the excretion of bicarbonate decreased significant-
ly, and returned to control values upon restoring normoxemia.
The reduction of renal blood was not accompanied by significant
changes in intrarenal blood flow distribution, as assessed by the
85Sr and 141Ce microsphere technique. Administration of dopa-
mine, 15 zg/kg mm, to normal animals was followed by a signif-
icant increase in GFR and effective renal plasma flow, without
changing blood pressure. The effect of hypoxemia in these dopa-
mine-treated animals was similar to that observed in control ani-
mals. Similarly, furosemide or NaHCO3-induced diuresis could
not prevent the effect of hypoxemia on renal function. It is con-
cluded that acute normocapneic hypoxemia induces a state of
renal vasconstriction with decreased electrolyte excretion, with-
out changing intrarenal blood flow distribution.
Micropuncture study of relationship between potassium (K) and
ammonium (NH4) renal transport. P. Jaeger, B. Karlmark, and
G. Giebisch. Yale University School of Medicine, Dept. of Physi-
ology, New Haven, Connecticut, USA. It has been shown that
acute K-loading depresses NH4 excretion, chronic K depletion
increases NH3 production, and a primary increase in NH3 pro-
duction, by glutamine infusion, depresses K excretion. To study
the nephron site and mechanisms of this relationship, we carried
out clearance and micropuncture experiments in four groups of
rats as detailed in the table. Micropuncture experiments were
done on proximal and distal tubules, and fluid was analyzed for
inulin, Na, K, and NH4. NH4 analysis was performed by titrating
samples after formaldehyde addition, using a glass pH electrode
system for pH measurements and an antimony system for addi-
tion of OH ions. The urinary NH4 excretion rates and the regres-
sion lines of NH4 concentration as a function of distal TF/P inulin
ratio are depicted in the table:
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NH4 excretion,
1sM/mifl
Distal [NH4]-
TF/P inulin
Controls (I) 1.07 0.05 y = O.38x + 3.03
Acute K-loading (II) 0.68 0.07 y = 0.32x + 1.35
Chronic K depletion (III) 2.31 0.30 y = 0.87x + 2.55
Acute NH-1oading (IV) 2.02 0.25 y = 0.40x + 5.14
Mean late proximal NH4 concentration was identical in I and II,
whereas it was significantly elevated in III. At comparable distal
nephron sites, tubular K concentrations were identical in I and
IV. Conclusions. Acute K-loading decreases NH3 production
mainly beyond the superficial distal tubule. Chronic K depletion
increases NH3 production proximally and distally. The primary
increase in NH3 production by glutamine occurs prior to the dis-
tal tubule, while the K-sparing effect takes place beyond the dis-
tal tubule.
Effects of chronic alpha and beta adrenoceptor blockade with
labetalol on catecholamines and renal function in hypertension. G.
Keusch, P. Weidmann, W. H. Ziegler, R. DeChdtel, and F. C.
Reubi. Medizinische Poliklinik, University Bern, Switzerland.
Plasma and urinary catecholamines, and renal function were
evaluated in 18 patients with essential hypertension treated with
the alpha and beta adrenoceptor blocking agent labetalol. Fol-
lowing 6 weeks of labetalol therapy, there was a 3.9-fold increase
in renal epinephrine clearance (from 101.4 31.2 to 393.8 85.7
mllmin/l.73 m2; P < 0.01) and a 3.2-fold rise in fractional epi-
nephrine clearance (from 1.43 0.50 to 4.45 0.83;P < 0.01),
while blood levels of epinephrine remained unchanged. Norepi-
nephrine blood levels and clearance remained unaltered. Blood
volume was expanded by 17% (P < 0.025). GFR and renal
plasma flow were decreased similarly by about 16.6 and 21.0%,
respectively (P < 0.025). Since tubular rejection fraction of so-
dium was increased, sodium excretion was comparable to con-
trol conditions. The lack of increased plasma catecholamine lev-
els during therapy supports the concept that labetalol's alpha
blocking potential is limited to postjunctional receptors, leaving
the prejunctional feedback control of catecholamine release in-
tact. Under basal conditions, epinephrine may be both filtered
and secreted by the kidney. Labetalol seems to stimulate tubular
release of epinephrine, possibly by augmenting intrarenal pro-
duction. The increase in tubular rejection fraction of sodium dur-
ing chronic labetalol therapy may be a consequence of the de-
crease in glomerular filtration rate, blood volume expansion and!
or alpha adrenergic inhibition.
The renin type of essential hypertension and the relationship be-
tween plasma catecholamines, renin, and age. W. Kiowski, 0.
Bertel, and F. R. Bühler. Departement für Innere Medizin, Mcd-
izinische Universitdtsklinik, Kantonsspitul, Basel, Switzerland.
The relationships between age, plasma norepinephrine, epineph-
rifle, and PRA were analyzed in 20 normal subjects and 33 pa-
tients with essential hypertension; 13 had a high, 15 a normal,
and 5 a low-reninlsodium index. An age-dependent increase in
plasma norepinephrine was observed in normal subjects, but in
the essential hypertensive patients it was found only after ex-
clusion of the high-renin patients who were younger and often
had supranormal values. Plasma epinephrine was higher in hy-
pertensive patients; it did not correlate with age or renin. In am-
bulatory, upright patients renin correlated inversely with age.
Renin was directly related to plasma norepinephrine in high- and
normal-renin patients. Thus the fractional distribution of the re-
nm subtypes in a given sample of patients greatly influences the
presence or absence ofa correlation between norepinephrine and
age or renin. The high plasma norepinephrine concentrations in
the young high-renin patients can be interpreted as reflecting
sympathetic overactivity. Sympathetic nerve activity appears to
govern renin secretion in high and normal renin patients, while in
the low renin patients the relatively high plasma riorepinephrine
concentrations point toward a defect in the neuroeffector system
which may be due to the older age of these patients and/or to the
longer duration of their hypertension.
Childhood urolithiasis: Experience with 59 patients. E. P. Leu-
mann, D. Rainer, and U. Stauffer. Medizin. und Chirurg. Abt.
der Univ.-Kinderklinik, Zurich, Switzerland. Between 1969 and
1977 (8.5 years), 59 children with urolithiasis were seen. Calculi
were available from 52 children and could be analyzed using
X-ray diffraction in 50 children. Results: Age, sex. Half of pa-
tients were less than 4-years old, and in this group, males greatly
predominated (22/29 = 76%). In contrast, 60% of the older chil-
dren (18/30) were female. Location of calculi: Renal pelvis (45)
and/or ureter (20), bladder (5, of which 2 were idiopathic), ure-
thra (2). Composition according to predominant constituents and
age:
0 to 5 5 to 10 10 to 16 yr
Calcium oxalate 7 7 6
Calcium phosphate 4 1 —
Struvite (including 1 fibrin) 14 3
Cystine 4 3 —
Uric acid I — —
Etiology: (a) Infectious (26 44%): In 19 pts, infection was sec-
ondary to urinary tract malformation and 76% of stones con-
tained struvite. (b) Metabolic (15 = 25%): cystinuria (7), primary
hyperoxaluria (3), hypercalciuria (5: 3 idiopathic, 2 after immobi-
lization). (c) Undetermined (18 = 31%): 87% were calcium
stones. Recurrence rate was highest in the metabolic group
(100% in hyperoxaluria and 71% in cystinuria) except in hyper-
calciuria (0). It was 29% in the infectious group and 15% in the
group of undetermined etiology. Conclusion. Childhood urolith-
iasis is predominantly seen in males <4 years and is usually
secondary to a definable cause.
Natrinretic factor in rat's renal tissue following acute expansion:
Its dependence on basal sodium intake. F. Louis, and II. Favre.
Division de Nephrologie, Département de Médecine, Hopital
Cantonal, Geneve, Switzerland. The influence of basal sodium
intake on the activity of the natriuretic factor (NF) found in rat
renal tissue after acute expansion was studied. Two series of
male Wistar rats were submitted over a week to various salt in-
takes and the experiments performed after an 18-hour fast peri-
od. The first series included three groups of rats: group A fed a
0 mEq Nalday diet, group B 3 mEq Na/day, group C 6 mEq
Na/day. After three 20-minute clearance periods, kidneys were
removed and homogenized. The NF was prepared using the
method previously described for human urine (Sephadex 0-25
chromatography). Its activity was assayed on normal unanes-
thetized rats and expressed as changes of FEN, between control
and experimental periods. Rats from the second series were di-
vided in three similar groups based on sodium intake. On the
day of experiment, all rats were expanded with isotonic saline
to 10% of body weight (groups AE, BE, CE). The remaining ex-
perimental design was identical to the one described above. In
the first series, the activity of the NF found in the renal tissue
paralleled the degree of oral salt intake: 0.4% for group A, 8.2%
for group B, 30% for group C. Similarly, after acute expansion,
second series, the activity of the NF averaged 123.5% for group
AE, 317.2% for group BE, 425.1% for group CE. Statistically
significant differences were found between group A vs. AE:
P <0.01, group B vs. BE: P <0.0025, group C vs. CE: P <0.025.
NF activity of group BE and CE rats was statistically higher
than that of group AE (P < 0.01). When the rats from all groups
were considered there was a strong relationship between the
FE5 of the donor rats and the activity of the NF found in
their kidneys (r = 0.744, P < 0.0005). NF activity found after
acute expansion depends on the basal salt intake of the animal.
These results emphasize that the NF plays also a role in the regu-
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lation of the acute sodium balance in addition to the one pre-
viously described in chronic experiments.
Interactions of acid-base changes and furosemide on tubular cal-
cium transport. C. Marone and R. A. L. Sutton. University of
British Columbia, Vancouver, Canada. The direct effects of
acute metabolic acidosis and alkalosis upon renal calcium trans-
port are uncertain. To examine these changes in tubular calcium
reabsorption after acute acid-base changes, we performed clear-
ance experiments in three groups of 10 acutely thyroparathyroid-
ectomized rats, following the infusion of isotonic NaCI (control),
NH4C1, or NaHCO3. In a second phase, a maximal dose of fu-
rosemide was administered, and the interactions with the acid-
base changes were examined. In the first phase, fractional excre-
tion (FE) of sodium was 4.2, 6.1 (P < 0.05), and 3.3%, respec-
tively, while FECa was higher in acidosis (14.8%, P <0.001) and
lower in alkalosis (1.9%, P < 0.01) than in controls (5.0%). The
administration of furosemide increased FENa to a similar degree
in all groups (17.1, 21.2 (P <0.05) and 16.2%, respectively) while
FECa increased more markedly in acidosis (36.4%, P < 0.001)
and less markedly in alkalosis (8.5%, P < 0.01) than in the con-
trols (14.5%). These results demonstrate that acute acidosis in-
hibits, and acute alkalosis enhances, the renal tubular reabsorp-
tion of calcium in the rat. Furthermore, the persistence of these
effects in the presence of furosemide, which is believed to inhibit
Na and Ca transport in the ascending limb of Henle's loop, sug-
gests that the acid-base effects on calcium reabsorption occur at
a separate, and probably more distal site in the nephron.
Tubular handling of phosphate in thyroparathyroidectomized
rats treated with 1,25-dihydroxyvitamin D3: Micropuncture stud-
ies. R. Mühlbauer, J. P. Bonjour, and H. Fleisch. Patho-
physiologisches Inst it ut der Universitdt Bern, Bern, Switzerland.
Clearance studies in vitamin D-replete thyroparathyroidecto-
mized (TPTX) rats have shown that chronic administration of
1,25-dihydroxyvitamin D3 (l,25(OH)2D3, 2 x 13 pmoles/day i.p.
for 7 days) decreases the overall tubular capacity to reabsorb
inorganic phosphate (P1). In the present work, the influence of
1 ,25(OH)2D3 on the tubular handling of P1 was localized by free-
flow micropunctures and compared to the effect of (1) dietary
increase of P1 in TPTX rats, and (2) chronic thyroparathyroidec-
tomy. The influence of 1,25(OH)2D3, dietary P1, and chronic
thyroparathyroidectomy were studied at similar plasma P, con-
centration ([P,]1) after correcting any difference in [P1]1. due to
pretreatment by acutely infusing P1. In TPTX rats the administra-
tion of 1,25(OH)2D3, or an increase in dietary phosphorus from
0.2 to 1.2%, inhibited net P, reabsorption from glomerulus to
early proximal but not from early to late accessible proximal tu-
bule. Removal of the thyroparathyroid glands did not alter signif-
icantly net P, reabsorption along the first portion of the proximal
tubule when measured at similar filtered load of P1 48 hours after
the operation. However, in chronic TPTX rats an increase in net
P reabsorption from early to late accessible proximal tubule was
observed. 1,25(OH)2D3 and dietary P1 increased whereas chronic
TPTX decreased the P1 delivery from superficial distal tubules to
the final urine. In conclusion, this study indicates that
I ,25(OH)2D3 given to TPTX rats affects the P, transport along the
same tubular segments as does an increase in dietary P1. Along
the proximal tubule the localization of the influence of
l,25(OH)2D3 and dietary P, differs from that of chronic TPTX.
Finally, the results also suggest that the terminal nephron may
also respond to l,25(OH)2D3, dietary P1, and chronic thyropara-
thyroidectomy.
"Activation" of kidney and plasma renin of normal rats: A se-
ries of methodologic artifacts. L. Peters, L. Kohier, T. Berger,
and J. Atkinson. Inst it ut de pharmacologic de 1' Université, Lau-
sanne, Switzerland. Homogenates of rat renal cortex (10 mg/ml)
were either dialyzed for 24 hours at pH 2.5 and for another 24
hours at pH 6.5 (or 7.5), or left undialyzed (controls). The ho-
mogenates were then diluted and incubated for 1 hour with ho-
mologous substrate. The renin in a homogenate diluted to 0.06
mg tissue/ml incubate appeared to be activated" by the acid-
neutral dialysis: it yielded twice as much angiotensin I (Al) than
control. The increased yield was due to more complete inhibition
of angiotensinases, inadequately inhibited by the EDTA present
(20 mM): the recovery of Al, added as such, was increased to
90% (dialysis) from 60% (controls). Dilution of the homogenate
to 0.006 mg tissue/ml incubate, without or with dialysis, in-
creased Al recovery to 96 5% and, thereby, apparently also
"activated" renin. In rat plasma, the "activation" of renin by
dialysis of pH 3.3 and subsequently at pH 6.5 or 7.5 was due: (I)
to a formation of Al during dialysis (up to 30% of Al formed
during the subsequent incubation with substrate)—acid dialysis
destroyed angiotensinases and preserved this Al; (2) an inhibi-
tion of the inactivation of rat plasma renin at pH 7.5 by the pre-
ceding acid dialysis.
Epidemiologic study (1968—78) to assess a relationship between
excessive use of phenacetin-containing analgesics and subsequent
development of urorenal disorders: Comparison of women who de-
veloped or not renal insufficiency until 1975. E. Pfister and U. C.
Dubach. Medizinische Universitdts-Poliklinik, Department für
Innere Medizin, Kantonsspital Base!, Switzerland. In this longi-
tudinal investigation, a study group of 623 women (30 to 49 years
old) with objective evidence of high intake of analgesics (urine
analyzed for the presence of N-acetyl-p-aminophenol (NAPAP),
the main metabolite of phenacetin), showed a significantly higher
incidence (5.5%) of abnormal levels of serum creatinine (5; 1.51
mg%) than a matched control group with no evidence of high
intake (0.8%). The case histories (with regard to urorenal infec-
tions and disease, hypertension, streptococcal infections, pat-
tern and duration of intake of analgesics, cigarette smoking) and
laboratory data (proteinuria, hematuria, urine specific gravity af-
ter thirsting overnight, bacteriuria, urine NAPAP and salicylate
concentrations) of 27 women from the study group, who in 1975
showed a serum creatinine level of 1.51 mg% (group A) were
compared to the correspondent data of 27 women from the same
group, but with normal serum creatinine levels (group B). These
controls were matched with regard to age, parity, nationality,
marital status, and type of work. The comparison yielded no
relationship between the manifestation of renal insufficiency and
the duration of frequency of intake of analgesics. Surprisingly,
the women of group B often showed higher concentrations of
NAPAP and salicylate in their urine. The case histories seem to
indicate that additional factors such as urorenal infections and/or
hypertension favor the development of renal insufficiency,
though bacteriuria was equally frequent for the two groups. The
women of group B smoke twice as much as those of group A.
Together with the higher concentrations of NAPAP and salicy-
late, this could point to a more pronounced tendency to addiction
in this group. On the other hand, this behavior might be con-
nected with the known influence of cigarette smoking on phen-
acetin metabolism.
Renal mercury content in mercuric chloride-induced acute renal
failure (ARF) in protected and nonprotected rats. D. de Rouge-
mont, M. Robbiani, F. P. Brunner, H. G. Seiler, and G. T. Thiel.
Department für innere Medizin, Universitdt Base!, Switzerland.
Pretreatment of rats with afurosemide infusion induces a marked
diuresis and thus attenuates HgCl2-induced ARF. To investigate
whether a relation exists between renal mercury content and de-
gree of protection, we measured mercury (atomic absorption
spectroscopy) in kidney and urine 48 hours after different HgCI2
doses, with (groups A1 to D1) or without (groups A2 to D2) furose-
mide administration. Groups A1 to D1 were given 2, 3, 6, or 10mg
HgCl2 s.c. Groups A2 to D2 were continuously infused with 96
mI/day of saline containing furosemide (100 mg/liter), 2 days be-
fore, during, and after 2, 3, 6, or 10 mg HgCI2/kg s.c.
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Dose
HgCl2,
mg/kg Furos.
Plasma
creatinine,
mg/dl
Renal mercury
content,
pgHg/g dry wt
Urinary Hg
excretion
pg/24 h
A, 2 — 4.6 1.4 50.1 4.3 32.8 17.8
A2 + 1.3 0.1 50.0 4.6 34.7 4.6
B 3 — 7.4 0.2 53.4 1.9 9.6 7.9
B2 + 1.1 0.1 47.1 3.5 39.7 10.1
C 6 — 8.6 0.4 64.8 7.1 anuria
C2 + 1.6 0.2 72.1 8.0 43.8 5.2
D1 10 — 8.2 0.1 75.9 14.3 anuria
D2 + 2.6 0.2 55.9 4.8 20.7 2.7
Thus, renal mercury content did not correlate with renal function
after HgCI2 administration. Protection by furoseinide was neither
due to lower renal mercury content, nor to a more rapid elimina-
tion of mercury.
Duodenal mucosal calcium ATPase activity in uremic rats: Ef-
fect of low-dose 1,25 dihydroxycholecalciferol treatment and rela-
tionship to calcium transport in vitro. H. Schiffi and U. Binswan-
ger. Nephrologische Station, Universitdtsspital Zdrich, Switzer-
land. The calcium ATPase activity (jzmoles/hrmg) was mea-
sured in duodenal cells of partially nephrectomized (nx) and
sham-operated (c) rats. Uremia decreased the enzyme activity
(nx: 3.11 0.19 vs C: 4.18 0.27, P <0.005) and impaired the
rise following calcium deprivation as observed in c rats (nx: 3.56
0.21 vs c: 5.78 0.38. P < 0.0005). Low dose of 1.25 dihy-
droxycholecalciferol increased the enzyme activity in uremic
rats by 78% and resulted in an identical response to calcium dep-
rivation as observed in intact rats (nx: 7.77 0.40 vs. c: 7.88
0.16, NS) A striking correlation between calcium transport in
everted duodenal gut sacs and Ca-ATPase activity could be dem-
onstrated for all groups of rats studied (r = 0.9). It is concluded,
that the Ca-ATPase activity is linked to the production of 1,25
DHCC as well as to an additional factor, probably parathyroid
hormone. The close relationship between the enzyme activity
and in vitro calcium transport suggests an autonomous role of the
calcium ATPase in addition to the well-known vitamin D-related
mechanisms for mediation of calciuni transport in the duodenum.
Human renal fluoride excretion: Alterations observed in renal
failure. H.Sc hiffi, U. Flueler, and U. Bins it'anger. Nephrolo-
gische Station, Universitiitsspital Zurich, Switzerland. Fluoride
(F) and crealinine (Cr) clearances were measured in healthy vol-
unteers (group I, N 9, patients with advanced (group 2, N =
8) or endstage renal failure on hemodialysis (group 3, N = 7) by
measuring F (Orion electrode 96-09) and Cr in serum and 24-hour
urine. Results were as follows (mean so):
Group 1 Group 2 Group 3
Cr clearance
mi/mm 127.6 44.6 22.4 18.3 1.5 0.9
F clearance,
,nl/,nin 28.7 8.8 6.2 4.3 0.9 0.6
F/Cr clearance 0.25 0.07 0.33 0.16 0.64 0.24
Urinary excretion
F,pg/24hr 452.2 260.2 145.8 91.5 55.5 38.7
Serum conc,
F, pg/rn! 10.5 3.3 21.1 11.8 45.0 14.7
An inverse relationship between serum F and Cr clearances was
observed (y = 44.42 . x°31, r 0.88), indicating that serum F
increases when Cr clearance is 25 mI/mm. It is concluded that
with progressing renal failure the urinary fluoride excretion is
decreased proportionally to GFR. In end-stage renal disease, de-
pression of F tubular reabsorption additionally occurs.
Blockade of the renin system by captopril in patients with "un-
controllable" hypertension on hemodialysis. J. P. Wauters, B.
Waeber, H. R. Brunner, C. A. Turini, J. P. Guignard, and H.
Garras. Centre Hospilalier Universitaire Vaudois, Lausanne,
Switzerland. Severe 'uncontrollable" hypertension in patients
on maintenance hemodialysis is thought to be due to a spontane-
ously overactive renin system responding moreover in-
appropriately to induce sodium depletion. Oral administration of
a new angiotensin-cnnverting enzyme inhibitor, captopril or SQ
14,225, to such patients made it possible to test this hypothesis
by chronically blocking the generation of angiotensin 11. Capto-
pril was given in two daily doses of 50 to 200 mg to six patients,
aged 10 to 39 years, on maintenance hemodialysis for 0.5 to 7
years. All patients had hypertension refractory to ultrafiltration
and conventional antihypertensive therapy, and during the last
month of preceding therapy, the blood pressure averaged 187/112
11/5 pre- and 187/104 11/3 mmHg (mean 5EM) post-dial-
ysis. Before captopril treatment, PRA off antihypertensive thera-
py ranged from 0.71 to 90.0 nglmllhr. Captopril together with
ultrafiltration markedly reduced blood pressure in all but one pa-
tient who exhibited the lowest renin value. After 18 6 weeks of
this treatment, blood pressure averaged 151/83 13/7 mmHg
pre- and 152/83 8/6 mmHg post-dialysis, while body weight
had increased by 1.4 2.8 pre- and 2.1 2.7% post-dialysis.
Conclusion. Uncontrollable" hypertension in patients on main-
tenance hemodialysis seems to be sustained predominantly by
renin levels that are inappropriate for a given amount of body
sodium. Chronic inhibition of angiotensin-converting enzyme by
captopril treatment neutralizes the pressor effect of the renin sys-
tem both before and after sodium depletion. Thus, it becomes
possible to titrate the amount of sodium that is present in excess
and needs to be eliminated to normalize blood pressure.
Age versus urinary sodium for judging renin, aldosterone, and
catecholamine levels. P. Weidmann, C. Beretta-Piccoli, W. H.
Ziegler, G. Keusc/i, and Z. Cluck. Medizinische Poliklini/t, Uni-
versity Bern, Switzerland. The relative influence of sodium bal-
ance and age on PRA, aldosterone (PA), norepinephrine (NE),
and epinephrine (F) levels, and urinary NE or E measured in an
outpatient setting was evaluated in 90 normal subjects and 79
patients with benign essential hypertension. Ranges of age (17 to
76 years) and urinary sodium (UNa) (51 to 241 mEq/24 hr) were
comparable. In normal subjects, supine or upright PRA and su-
pine plasma F correlated (P <0.05) inversely, and supine plasma
PNE or NE excretion correlated positively with age, but not with
U5; while upright plasma NE correlated closer with age than
with U5a. Supine PA correlated with both age and Usa; upright
PA only with U5a. Based on significant relationships with either
age or UNa, dynamic normal ranges with 95% confidence limits
could be established. Hypertensive patients exhibited also age
related decreases in PRA and PA and increases in NE; PRA and
PA did not correlate with Usa. Consideration of age revealed low
or high PRA in 10 and 5%, respectively; these abnormalities oc-
curred more commonly with moderate-severe (> 160/105 mm
Hg) than with mild hypertension and were associated with paral-
lel variations in age-adjusted plasma NE. Nevertheless, plasma
NE was within the normal range, except for slightly low upright
values in 15% of patients. PA related to age or Ua was increased
in 25% of patients while supine, but was usually normal in the
upright position. These findings demonstrate that without pro-
found sodium depletion, age may be more important than sodium
excretion as frame of reference forjudging both renin and norepi-
nephrine measurements; both factors should be considered for
interpretation of PA. On this basis, one fourth of patients with
essential hypertension have mild hyperaldosteronism while
maintaining the supine position. Low-renin hypertension is much
less common than previously suggested and may be related to
low adrenergic activity.
Prevention of hepatitis-B with immunoglobulin antihepatitis-B
in hemodialysis patients and personnel. K. Zdruba, H. Joller, and
P. Grab. Nierenstation Sfadtspital Waid Zurich and Abteilung
für klinische Immunologic, Departement fur Innere Medizin,
Universitiitsspital Zurich, Switzerland. During a 12-month peri-
od (April 1977—March 1978), 11 hemodialysis patients and staff
members of a total of 95 persons at the Dialysis Centre Stadtspit-
a! Waid Zurich became HBs-Ag positive. These include 10 cases
with clinical hepatitis-B. To prevent spreading of the infection,
until a separation of HB-Ag positive from HB-Ag negative pa-
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tients in the dialysis unit is possible, a passive immunization with
immunoglobulin antihepatitis-B SRK-human (Titer 1:4000) was
started. Only HB5-Ag and HBs-antibody-negative patients and
staff members were immunized: 4 ml of immunglobulin was ad-
ministered i.m. during an average of 2 months. Only one case of
clinical hepatitis-B occurred among the immunized dialysis pa-
tients and one patient became transiently (1 month) HBs-Ag-pos-
itive during the 7 months following the passive immunization.
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